◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Kaken Pharmaceutical Co., Ltd. (4521) Financial History

Name: Kaken Pharmaceutical Co., Ltd. (4521) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

Kaken Pharmaceutical Co., Ltd. (4521) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Tokyo, Japan with about 1,114 employees. Its market capitalization is roughly JPY 151 billion. In the fiscal year ended 2026-03-31, 4521 reported JPY 76.9B in revenue and JPY 2.1B in net income.

Kaken Pharmaceutical Co., Ltd. produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.

Interactive charts & full statements →

4521 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	JPY 76.9B	JPY 94.0B	JPY 72.0B	JPY 73.0B
Gross Profit	JPY 40.0B	JPY 58.5B	JPY 38.5B	JPY 39.6B
Operating Income (EBIT)	(JPY 897M)	JPY 21.0B	JPY 9.5B	JPY 8.0B
Net Income	JPY 2.1B	JPY 13.9B	JPY 8.0B	JPY 5.4B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4521 Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(JPY 6.5B)	(JPY 7.2B)	(JPY 5.7B)	(JPY 5.6B)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4521 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	JPY 178.2B	JPY 193.4B	JPY 171.6B	JPY 166.3B	—
Total Liabilities	JPY 30.6B	JPY 40.7B	JPY 27.9B	JPY 29.5B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4521 viewer.

4521 Metric Deep Dives

Other Companies in Drug Manufacturers - Specialty & Generic

3692 · Hansoh Pharmaceutical Group Company Limited — $200 billion
4887 · Sawai Group Holdings Co., Ltd. — $184 billion
4553 · Towa Pharmaceutical Co., Ltd. — $182 billion
4547 · Kissei Pharmaceutical Co., Ltd. — $171 billion
TEVA · Teva Pharmaceutical Industries Limited — ₪125 billion
4534 · Mochida Pharmaceutical Co., Ltd. — $114 billion
4559 · Zeria Pharmaceutical Co., Ltd. — $91 billion
4569 · KYORIN Pharmaceutical Co., Ltd. — $64 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← 4519 All “0-9” companies 4523 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.